Brief: Wilex H1 net loss up 26 pct at EUR 2.4 mln
July 14 (Reuters) - Wilex AG WL6G.DE :
* H1 sales revenue and income totalling 1.9 million euros ($2.11 million), down 17 percent
on previous year (2.3 million euros)
* Net loss for first half of year rose by 26 percent to 2.4 million euros from 1.9 million
euros
* There is no change to guidance for Wilex Group for current financial year issued at end of
march 2016
Source text for Eikon: ID:nEQ3wNqCs
Further company coverage: WL6G.DE
($1 = 0.9003 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Heidelberg Pharma AG
See all newsBrief: Heidelberg Pharma And Huadong Medicine Receive Nmpa Approval For Hdp-101 Trial In China
Germany's Heidelberg Pharma H1 sales revenue surges, driven by milestone payments
Brief: Heidelberg Pharma Says Co. And Healthcare Royalty Announce Amendment To Existing Royalty Agreement
Brief: Redhill Biopharma Secures Allowance Of Key Chinese Patent Application For Proprietary COVID-19 Treatment, RHB-107
Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty